ACB
Aurora Cannabis IncNASDAQ
Healthcare • Drug Manufacturers - Specialty & Generic
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Quality Micro Cap
$4.29-1.38%
Close Oct 13, 2026
- Market cap
- $264.6M
- 1 month
- +12.6%
- 3 months
- +61.3%
- 1 year
- -19.1%
- 52-week range
- $2.58$5.63
- Dividend
- No payments on record
- Short interest
- 7.6M sharessettled Sep 30, 2026 · +2.7% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if ACB is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
24 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
144 filers reported a long position in ACB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | $3.8M | 1.4M | +27.9% |
| Tidal Investments LLC | $3.5M | 1.3M | +1.2% |
| RENAISSANCE TECHNOLOGIES LLC | $2.2M | 785K | +3.5% |
| NATIONAL BANK OF CANADA /FI/ | $672.5K | 241.1K | -11.1% |
| MORGAN STANLEY | $671.5K | 240.7K | -7.1% |
| UBS Group AG | $495.4K | 177.6K | +16.6% |
| AdvisorShares Investments LLC | $477.4K | 171.1K | Unchanged |
| Sculptor Capital LP | $289.3K | 103.7K | — |
| CITIGROUP INC | $276.2K | 99.2K | +127.9% |
| TD ASSET MANAGEMENT INC | $263.5K | 94.7K | +6.4% |
Get the Full Analysis for ACB
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.